EXPERT GUIDANCE
Regressed GCs: Grade 2
Plasmacytosis: Grade 1
FDC prominence: Grade 2
Vascularity: Grade 2
Hyperplastic GCs: Grade 1
This lymph node is characterised by a very
prominent regression of GCs (Grade 2). The GCs contain
very little residual centrocytes and centroblasts,
giving rise to prominence of FDCs (Grade 2). There is only
mild vascularity inside the GCs, with only
sporadic penetrating vessels. However there is
a prominent vascular expansion in the paracortex (Grade 2). Some plasmacytosis is present (Grade 1).
With this histopathological picture iMCD can be considered, but a chronic viral infection (HIV, EBV),
auto-inflammatory disorder, and angioimmunoblastic T-cell lymphoma, should be ruled out. Additional stains
that
are necessary to perform in this context are: CD21, CD4,
PD1,
ICOS, HHV-8, EBER in situ hybridization. TCR PCR can be performed to rule out T-cell clonality.
The following images are provided, CD21 shows no increased
FDC networks surrounding the high endothelial venules in the paracortical area, as one should expect in AITL;
CD20 shows the lack of centrocytes and centroblasts in the
GCs, corresponding to the small amount of BCL2-negative
cells.
Abbreviations
AITL, Angioimmunoblastic T-cell lymphoma; EBV, Epstein-Barr virus; GCs, germinal centres; FDC, follicular
dendritic cell;
HHV-8, human herpes virus-8; HIV, human immunodeficiency virus; iMCD, idiopathic Multicentric Castleman
Disease.
This tool has been funded and produced by Recordati Rare Diseases (RRD). All images have been
provided
by an international
panel of expert pathologists. The concept, functionality and expert guidance found within this tool has also
been developed with the support of expert pathologists.